Emergency Management of Hemoptysis
In patients presenting with massive hemoptysis (>240 mL/24h or any amount causing respiratory compromise), immediately secure the airway with a single-lumen cuffed endotracheal tube, establish large-bore IV access, deliver high-flow oxygen, and proceed directly to bronchial artery embolization without prior bronchoscopy or CT imaging—delays for diagnostic procedures significantly increase mortality. 1
Immediate Assessment (First 5 Minutes)
Severity stratification determines all subsequent management:
- Scant hemoptysis: <5 mL/24h 1
- Mild-to-moderate: 5–240 mL/24h 1
- Massive: >240 mL/24h OR any amount causing respiratory distress, hypoxia, or hemodynamic instability 1, 2
Critical point: The rate of bleeding predicts mortality more accurately than total volume—rapid bleeding with hypoxia constitutes massive hemoptysis regardless of measured quantity 1, 2.
Airway Management for Massive Hemoptysis
Intubate immediately with a single-lumen cuffed endotracheal tube (NOT double-lumen) to permit therapeutic bronchoscopy and clot removal 1, 3. Double-lumen tubes are harder to place and limit bronchoscope passage 1.
- Position patient in lateral decubitus with bleeding side down if the side is known, to protect the non-bleeding lung 4
- Consider selective mainstem intubation to isolate the non-bleeding lung 1
- Deliver high-flow oxygen at 15 L/min via reservoir mask when SpO₂ <85%, then titrate to maintain 94–98% 1
Resuscitation Protocol
Establish large-bore IV access (ideally 8-Fr central line) for volume resuscitation and potential transfusion 1.
Obtain baseline labs immediately:
- Complete blood count
- PT/aPTT
- Clauss fibrinogen (NOT derived fibrinogen—derived levels are misleading) 1
- Type and cross-match 1
Actively warm the patient and all transfused fluids to prevent hypothermia-induced coagulopathy 1.
Definitive Management by Severity
Massive Hemoptysis (Unstable Patients)
Proceed directly to bronchial artery embolization (BAE) without preceding bronchoscopy or CT imaging—this achieves immediate hemostasis in 73–99% of cases 1, 5, 3. Delaying BAE for diagnostic procedures markedly increases mortality 1, 6.
Bronchoscopy in unstable massive hemoptysis is performed ONLY for:
Bronchoscopic temporizing techniques while arranging BAE:
- Wedge bronchoscope tip into bleeding bronchus for tamponade 1
- Instill iced saline to constrict vessels 1
- Deploy bronchial blockade balloons 1
- Apply oxidized regenerated cellulose mesh (98% success rate) 1
Mild-to-Moderate Hemoptysis (Stable Patients)
Admit all patients with ≥5 mL hemoptysis for monitoring 1.
Immediate medical management:
- Stop all NSAIDs immediately—they impair platelet function and worsen bleeding 1
- Discontinue anticoagulants during active bleeding 1
- Start empiric antibiotics for any hemoptysis ≥5 mL (bleeding often represents pulmonary infection or exacerbation) 1
- Deliver supplemental oxygen via nasal cannula (2–6 L/min) or simple face mask (5–10 L/min) to maintain SpO₂ 94–98% 1
Diagnostic imaging:
- CT chest with IV contrast is the preferred initial test—provides 77% diagnostic accuracy versus 26% for chest radiograph alone 1
- Chest radiograph is reasonable only when confirming benign causes (acute bronchitis, pneumonia) 1
- CTA is standard of care if BAE is being considered, detecting aberrant bronchial arteries in 36% of cases and identifying pulmonary artery pseudoaneurysms missed on conventional arteriography 7, 1
Bronchoscopy indications in stable patients:
- Localize bleeding site when CT is nondiagnostic 1
- Identify anatomic side of bleeding 1
- Evaluate for visible central airway lesions amenable to endobronchial therapy 1
Scant Hemoptysis (<5 mL/24h)
Outpatient management is appropriate if this is not the first episode and bleeding is not persistent 1.
- Stop NSAIDs 1
- Antibiotics are NOT routinely indicated unless clinical features suggest infection 1
- Instruct patient to seek immediate care if bleeding increases 1
Critical Pitfalls to Avoid
Do NOT:
- Perform bronchoscopy before BAE in unstable patients—this delays definitive therapy and increases mortality 1, 5
- Use BiPAP in massive hemoptysis—positive pressure worsens bleeding 1
- Administer vasoactive agents (e.g., epinephrine) for massive bleeding—they are unlikely to be beneficial 1
- Stop airway clearance therapies in scant or mild-to-moderate hemoptysis—discontinuation is inappropriate 1
- Use double-lumen endotracheal tubes—they limit therapeutic bronchoscope access 1
- Rely on single hematocrit measurements as isolated markers of bleeding severity 1
- Use derived fibrinogen levels—they are misleading; use Clauss method 1
Do NOT stop in massive hemoptysis:
- Aerosolized bronchodilators and inhaled antibiotics may be continued 1
DO stop in massive hemoptysis:
- Aerosolized hypertonic saline—it exacerbates bleeding 1
- All airway clearance therapies to allow clot formation 1
Post-Intervention Management
Admit all patients to ICU after BAE for monitoring:
Start venous thromboprophylaxis as soon as bleeding is controlled 1.
Recurrence Risk & Follow-Up
Recurrence occurs in 10–55% of cases after BAE, with highest rates in:
For recurrent hemoptysis:
- Perform CT angiography or CT with IV contrast before repeat BAE for arterial mapping 1
- Repeat BAE does NOT increase morbidity or mortality 1
- Recurrence ≤3 months suggests incomplete embolization; >3 months suggests vascular collateralization or recanalization 1
Special Considerations
For aspergillomas: BAE followed by definitive surgical resection is recommended due to 55% recurrence rate with BAE alone 1.
For malignancy: BAE is typically palliative or a temporizing measure before definitive surgery 1.
Pulmonary artery source (10% of massive hemoptysis): CTA identifies pulmonary artery pseudoaneurysms that may be occult on bronchial arteriography; pulmonary artery embolization achieves 88–90% success rates 7, 1.